InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001156039-25-000030 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-05 2025-03-03 ELV LAVU RATNAKAR EVP, Chief Digital, Info Off A - Grant $0.00 +2,339 4,783 +96% $0
D 2025-03-05 2025-03-03 ELV LAVU RATNAKAR EVP, Chief Digital, Info Off F - Tax $395.50 -312 2,444 -11% -$123.4K
D 2025-03-05 2025-03-03 ELV LAVU RATNAKAR EVP, Chief Digital, Info Off A - Grant $0.00 +8,902 8,902 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-03 A A 2,339 $0.00 4,783 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 779 shares on 3/3/2026, and 780 shares each on 3/3/2027 and 3/3/2028.
2 Common Common Stock 2025-03-03 F D 312 $395.50 2,444 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
3 Derivative Employee Stock Option (Right to Buy) 2025-03-03 A A 8,902 $0.00 8,902 D $395.50 · — to 2035-03-03 8,902 Common Stock (F3) The option represents a right to purchase a total of 8,902 shares, and is exercisable in three annual installments, with two installments of 2,967 shares each and one installment of 2,968 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.